Michael Ganetsky

938 total citations
23 papers, 584 citations indexed

About

Michael Ganetsky is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Michael Ganetsky has authored 23 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 5 papers in Epidemiology. Recurrent topics in Michael Ganetsky's work include Atrial Fibrillation Management and Outcomes (7 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Poisoning and overdose treatments (4 papers). Michael Ganetsky is often cited by papers focused on Atrial Fibrillation Management and Outcomes (7 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Poisoning and overdose treatments (4 papers). Michael Ganetsky collaborates with scholars based in United States, Israel and France. Michael Ganetsky's co-authors include Kavita M. Babu, Brian Wolk, Steven D. Salhanick, Edward W. Boyer, Robert S. Brown, Maureen Chase, Russell E. Berger, Victor Novack, Steven Horng and Nathan I. Shapiro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Chemistry and Journal of the Neurological Sciences.

In The Last Decade

Michael Ganetsky

23 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Ganetsky United States 13 201 139 117 76 75 23 584
Karin Hedenmalm Sweden 15 80 0.4× 169 1.2× 61 0.5× 52 0.7× 78 1.0× 38 913
Bianca Kollhorst Germany 14 186 0.9× 183 1.3× 30 0.3× 71 0.9× 43 0.6× 51 721
Maja Hellfritzsch Denmark 18 311 1.5× 106 0.8× 152 1.3× 140 1.8× 26 0.3× 47 802
Christopher P Alderman Australia 16 74 0.4× 74 0.5× 24 0.2× 22 0.3× 35 0.5× 65 720
Thomas L. Lenz United States 16 210 1.0× 74 0.5× 27 0.2× 11 0.1× 79 1.1× 72 741
Elena Blasco‐Colmenares United States 17 544 2.7× 31 0.2× 35 0.3× 20 0.3× 47 0.6× 27 991
Célia Lloret‐Linares France 19 105 0.5× 206 1.5× 18 0.2× 37 0.5× 93 1.2× 51 1.1k
Craig G. Smollin United States 15 55 0.3× 108 0.8× 13 0.1× 27 0.4× 93 1.2× 41 619
E. Knight United Kingdom 8 611 3.0× 27 0.2× 188 1.6× 21 0.3× 17 0.2× 12 821
Mark K. Su United States 16 47 0.2× 216 1.6× 17 0.1× 31 0.4× 103 1.4× 76 801

Countries citing papers authored by Michael Ganetsky

Since Specialization
Citations

This map shows the geographic impact of Michael Ganetsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ganetsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ganetsky more than expected).

Fields of papers citing papers by Michael Ganetsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Ganetsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ganetsky. The network helps show where Michael Ganetsky may publish in the future.

Co-authorship network of co-authors of Michael Ganetsky

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Ganetsky. A scholar is included among the top collaborators of Michael Ganetsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Ganetsky. Michael Ganetsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganetsky, Michael, et al.. (2025). Perceptions and patterns of Cannabis use in emergency department patients following recreational legalization in Massachusetts. The American Journal of Emergency Medicine. 94. 31–36. 1 indexed citations
2.
Overbeek, Daniel L., et al.. (2021). A Geographically Distinct Case of Fatal Methanol Toxicity from Ingestion of a Contaminated Hand Sanitizer Product During the COVID-19 Pandemic. Journal of Medical Toxicology. 17(2). 218–221. 6 indexed citations
3.
Ganetsky, Michael, et al.. (2021). Impact of a Mandatory Prescription Drug Monitoring Program Check on Emergency Department Opioid Prescribing Rates. Journal of Medical Toxicology. 17(3). 265–270. 8 indexed citations
4.
Boyle, Katherine, et al.. (2020). Opioid-associated amnestic syndrome: Description of the syndrome and validation of a proposed definition. Journal of the Neurological Sciences. 417. 117048–117048. 23 indexed citations
5.
Zettervall, Sara L., et al.. (2019). Difficult Intraoperative Heparinization Following Andexanet Alfa Administration. SHILAP Revista de lepidopterología. 3(4). 390–394. 22 indexed citations
6.
Ganetsky, Michael, Anders H. Berg, Joshua J. Solano, & Steven D. Salhanick. (2018). Inhibition of CYP2E1 With Propylene Glycol Does Not Protect Against Hepatocellular Injury in Human Acetaminophen Daily‐Dosing Model. The Journal of Clinical Pharmacology. 59(1). 131–138. 7 indexed citations
7.
Milling, Truman J., et al.. (2017). Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review. Annals of Emergency Medicine. 69(5). 531–540. 5 indexed citations
8.
Bounes, Vincent, J. Levraut, Françoise Carpentier, et al.. (2016). Predicting morphine related side effects in the ED: An international cohort study. The American Journal of Emergency Medicine. 35(4). 531–535. 8 indexed citations
9.
Foley, Elizabeth, et al.. (2015). Risk of Venous Thromboembolism After Receiving Prothrombin Complex Concentrate for Warfarin-associated Intracranial Hemorrhage. Journal of Emergency Medicine. 50(1). 1–6. 17 indexed citations
10.
Ganetsky, Michael. (2015). Trends and Characteristics of Emergency Department Patients Prescribed Novel Oral Anticoagulants. Journal of Emergency Medicine. 49(5). 693–697. 19 indexed citations
11.
Ganetsky, Michael, et al.. (2014). Osmolal Gap without Anion Gap in a 43-Year-Old Man. Clinical Chemistry. 60(3). 446–448. 3 indexed citations
12.
Berger, Russell E., Steven D. Salhanick, Maureen Chase, & Michael Ganetsky. (2013). Hemorrhagic Complications in Emergency Department Patients Who Are Receiving Dabigatran Compared With Warfarin. Annals of Emergency Medicine. 61(4). 475–479. 36 indexed citations
13.
Ganetsky, Michael, Mark Böhlke, Luis M. Pereira, et al.. (2013). Effect of Excipients on Acetaminophen Metabolism and Its Implications for Prevention of Liver Injury. The Journal of Clinical Pharmacology. 53(4). 413–420. 15 indexed citations
14.
Wolk, Brian, Michael Ganetsky, & Kavita M. Babu. (2012). Toxicity of energy drinks. Current Opinion in Pediatrics. 24(2). 243–251. 155 indexed citations
15.
Ganetsky, Michael, Kavita M. Babu, Steven D. Salhanick, Robert S. Brown, & Edward W. Boyer. (2011). Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant. Journal of Medical Toxicology. 7(4). 281–287. 108 indexed citations
16.
Ganetsky, Michael, et al.. (2008). Non-fatal ventricular dysrhythmias associated with severe salicylate toxicity. Clinical Toxicology. 46(4). 297–299. 7 indexed citations
17.
Ganetsky, Michael, Kavita M. Babu, & Edward W. Boyer. (2007). Serotonin Syndrome in Dextromethorphan Ingestion Responsive to Propofol Therapy. Pediatric Emergency Care. 23(11). 829–831. 27 indexed citations
18.
Ganetsky, Michael, et al.. (2005). Serotonin Syndrome—What Have We Learned?. Clinical Pediatric Emergency Medicine. 6(2). 103–108. 18 indexed citations
19.
Bair‐Merritt, Megan, et al.. (2004). Pediatric Residency Training on Domestic Violence: A National Survey. Ambulatory Pediatrics. 4(1). 24–27. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Hedenmalm Breakdown of academic impact, for papers by Bianca Kollhorst Breakdown of academic impact, for papers by Maja Hellfritzsch Breakdown of academic impact, for papers by Christopher P Alderman Breakdown of academic impact, for papers by Thomas L. Lenz Breakdown of academic impact, for papers by Elena Blasco‐Colmenares Breakdown of academic impact, for papers by Célia Lloret‐Linares Breakdown of academic impact, for papers by Craig G. Smollin Breakdown of academic impact, for papers by E. Knight Breakdown of academic impact, for papers by Mark K. Su
Rankless by CCL
2026